ARTICLE | Clinical News
Brinavess IV vernakalant regulatory update
September 6, 2010 7:00 AM UTC
The European Commission, Iceland and Norway approved Brinavess IV vernakalant from Merck for converting recent onset atrial fibrillation (AF) to sinus rhythm in adults. Merck plans to launch the produ...